)
Cannara Biotech (LOVE) investor relations material
Cannara Biotech Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Fiscal 2025 achieved record highs in net revenue ($107.3 million), adjusted EBITDA ($28.1 million), net income ($13.1 million), and positive retained earnings, driven by capacity expansion and operational efficiency.
National market share rose to 3.81%, up 32% year-over-year, with Quebec market share increasing over 53% to 12.72%.
Cultivation capacity increased nearly 50% year-over-year, reaching the fiscal 2026 target a year early by activating two additional grow zones, totaling 12 and annual output of 50,000 kg.
The company remains focused on disciplined, efficient operations, quality products, and leveraging proprietary technology, including AI for cultivation optimization.
Launched new products and entered Quebec's vape cartridge category with 20% of accepted SKUs.
Financial highlights
Net revenue for the year was CAD 107.3 million, up 31% year-over-year, with gross revenue just under CAD 149 million.
Gross profit before fair value adjustments reached CAD 44.5 million (41% margin), up from 34% last year.
Adjusted EBITDA was CAD 28.1 million (26% margin), up from 18% last year; net income doubled to CAD 13.1 million.
Q4 revenue hit a record CAD 28.3 million, up 3.5% sequentially and 21% year-over-year; Q4 adjusted EBITDA rose 102% to CAD 7.5 million.
Free cash flow for FY25 was CAD 13.7 million, up from CAD 3.2 million in FY24; operating cash flow for the year was CAD 20 million.
Outlook and guidance
Management expects continued margin improvement as new rooms and post-processing capacity come online, targeting gross margins above 40% and potentially up to 50%.
Plans to operationalize 12 additional grow rooms at Valleyfield, potentially doubling cultivation capacity over four years.
Fiscal 2026 capital investment strategy prioritizes a new processing center, funded by a $10 million BMO term loan.
Steady, annual growth is anticipated, with no plans for rapid spikes or declines.
Focus on successful execution of the November vape category launch in Quebec and post-processing expansion at Valleyfield.
Next Cannara Biotech earnings date
Next Cannara Biotech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)